Free Trial

Alvotech (ALVO) Financials

Alvotech logo
$11.33 +1.05 (+10.21%)
Closing price 05/27/2025 04:00 PM Eastern
Extended Trading
$11.33 0.00 (0.00%)
As of 05/27/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Alvotech

Annual Income Statements for Alvotech

This table shows Alvotech's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020
Net Income / (Loss) Attributable to Common Shareholders
-232 -552 -514 -102 -164
Consolidated Net Income / (Loss)
-232 -552 -514 -102 -170
Net Income / (Loss) Continuing Operations
-232 -552 -514 -102 -170
Total Pre-Tax Income
-218 -651 -552 -149 -292
Total Operating Income
-145 -644 -522 -299 -138
Total Gross Profit
92 -335 -154 -23 69
Total Revenue
580 93 98 94 69
Operating Revenue
578 91 96 91 67
Other Revenue
2.30 1.95 1.99 2.91 2.83
Total Cost of Revenue
488 428 253 117 0.00
Operating Cost of Revenue
488 428 253 117 0.00
Total Operating Expenses
237 309 367 275 207
Selling, General & Admin Expense
66 77 187 84 59
Research & Development Expense
171 211 181 191 148
Impairment Charge
0.00 22 0.00 0.00 -
Total Other Income / (Expense), net
-72 -7.15 -30 149 -153
Interest Expense
69 0.00 27 -152 162
Interest & Investment Income
-2.97 0.00 0.00 - 5.61
Other Income / (Expense), net
0.00 -7.15 -2.59 -2.42 3.22
Income Tax Expense
14 -99 -38 -48 -122
Basic Earnings per Share
($0.87) ($2.43) ($2.60) ($0.92) ($1.82)
Weighted Average Basic Shares Outstanding
301.81M 266.82M 248.65M - -
Diluted Earnings per Share
($0.87) ($2.43) ($2.60) ($0.92) ($1.82)
Weighted Average Diluted Shares Outstanding
301.81M 266.82M 248.65M - -
Weighted Average Basic & Diluted Shares Outstanding
301.81M 266.82M 248.65M - -

Quarterly Income Statements for Alvotech

No quarterly income statements for Alvotech are available.


Annual Cash Flow Statements for Alvotech

This table details how cash moves in and out of Alvotech's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020
Net Change in Cash & Equivalents
-519 -57 -561 -14 -36
Net Cash From Operating Activities
-466 -312 -523 -228 -61
Net Cash From Continuing Operating Activities
-466 -307 -523 -247 -61
Net Income / (Loss) Continuing Operations
-232 -552 -514 -102 -170
Consolidated Net Income / (Loss)
-232 -552 -514 -102 -170
Depreciation Expense
31 24 20 18 16
Non-Cash Adjustments To Reconcile Net Income
-120 234 1.67 -132 207
Changes in Operating Assets and Liabilities, net
-145 -13 -31 -32 -114
Net Cash From Investing Activities
-54 -46 -38 -41 -7.41
Net Cash From Continuing Investing Activities
-54 -46 -38 -41 -7.41
Purchase of Property, Plant & Equipment
-54 -46 -38 -41 -7.49
Net Cash From Financing Activities
0.00 301 0.00 255 21
Net Cash From Continuing Financing Activities
0.00 310 0.00 262 21

Quarterly Cash Flow Statements for Alvotech

No quarterly cash flow statements for Alvotech are available.


Annual Balance Sheets for Alvotech

This table presents Alvotech's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021
Total Assets
1,221 950 828 598
Total Current Assets
455 195 231 120
Cash & Equivalents
51 11 66 18
Restricted Cash
0.00 26 25 10
Accounts Receivable
160 42 35 31
Inventories, net
128 74 71 39
Other Current Assets
115 67 58 33
Plant, Property, & Equipment, net
285 237 221 79
Plant, Property & Equipment, gross
285 237 221 79
Total Noncurrent Assets
482 492 344 382
Long-Term Investments
0.00 18 49 55
Goodwill
11 12 12 12
Intangible Assets
21 19 26 22
Noncurrent Deferred & Refundable Income Taxes
298 310 209 170
Other Noncurrent Operating Assets
152 133 49 123
Total Liabilities & Shareholders' Equity
1,221 950 828 598
Total Liabilities
1,634 1,883 1,393 734
Total Current Liabilities
193 261 167 112
Short-Term Debt
33 38 20 2.77
Accounts Payable
67 81 50 29
Current Deferred & Payable Income Tax Liabilities
0.20 0.93 0.93 0.84
Other Current Liabilities
93 141 96 79
Total Noncurrent Liabilities
1,441 1,622 1,226 622
Long-Term Debt
1,036 922 1,125 398
Capital Lease Obligations
112 106 35 115
Noncurrent Deferred & Payable Income Tax Liabilities
1.81 0.05 0.31 0.15
Other Noncurrent Operating Liabilities
291 594 57 45
Total Equity & Noncontrolling Interests
-413 -932 -564 -136
Total Preferred & Common Equity
-413 -932 -564 -136
Preferred Stock
2,007 1,230 1,058 1,000
Total Common Equity
-2,420 -2,162 -1,623 -1,136
Common Stock
2.83 2.28 2.13 0.14
Retained Earnings
-2,438 -2,206 -1,654 -1,141
Other Equity Adjustments
15 41 29 4.67

Quarterly Balance Sheets for Alvotech

No quarterly balance sheets for Alvotech are available.


Annual Metrics And Ratios for Alvotech

This table displays calculated financial ratios and metrics derived from Alvotech's official financial filings.

Metric 2024 2023 2022 2021 2020
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020
Growth Metrics
- - - - -
Revenue Growth
523.81% -5.21% 4.47% 35.25% 0.00%
EBITDA Growth
81.83% -24.39% -78.20% -139.85% 0.00%
EBIT Growth
77.70% -24.17% -74.21% -124.08% 0.00%
NOPAT Growth
77.45% -23.41% -74.75% -117.08% 0.00%
Net Income Growth
57.98% -7.43% -405.97% 40.31% 0.00%
EPS Growth
64.20% 6.54% -182.61% 49.45% 0.00%
Operating Cash Flow Growth
-49.14% 40.30% -129.16% -274.34% 0.00%
Free Cash Flow Firm Growth
-1,306.24% 90.31% -7.39% 0.00% 0.00%
Invested Capital Growth
824.37% -83.70% 60.02% 0.00% 0.00%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - -
Gross Margin
15.82% -360.12% -157.32% -24.94% 100.00%
EBITDA Margin
-19.63% -673.86% -513.52% -301.06% -169.77%
Operating Margin
-25.02% -692.20% -531.68% -317.85% -198.04%
EBIT Margin
-25.02% -699.89% -534.32% -320.43% -193.41%
Profit (Net Income) Margin
-39.96% -593.12% -523.36% -108.06% -244.85%
Tax Burden Percent
106.57% 84.74% 93.10% 68.03% 58.28%
Interest Burden Percent
149.82% 100.00% 105.21% 49.57% 217.22%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-25.60% -162.99% -94.52% -140.65% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
-37.78% -172.84% -114.67% -90.97% 0.00%
Return on Net Nonoperating Assets (RNNOA)
60.07% 236.70% 241.25% 290.34% 0.00%
Return on Equity (ROE)
34.47% 73.72% 146.73% 149.70% 0.00%
Cash Return on Invested Capital (CROIC)
-186.55% -19.05% -140.69% -340.65% 0.00%
Operating Return on Assets (OROA)
-13.37% -73.21% -73.52% -50.33% 0.00%
Return on Assets (ROA)
-21.36% -62.04% -72.01% -16.97% 0.00%
Return on Common Equity (ROCE)
117.41% 186.40% 578.22% 1,253.70% 0.00%
Return on Equity Simple (ROE_SIMPLE)
56.17% 59.17% 90.99% 74.85% 0.00%
Net Operating Profit after Tax (NOPAT)
-102 -451 -365 -209 -96
NOPAT Margin
-17.52% -484.54% -372.17% -222.50% -138.63%
Net Nonoperating Expense Percent (NNEP)
12.17% 9.85% 20.15% -49.67% 0.00%
Return On Investment Capital (ROIC_SIMPLE)
-13.24% -338.14% -59.31% - -
Cost of Revenue to Revenue
84.18% 460.12% 257.32% 124.94% 0.00%
SG&A Expenses to Revenue
11.32% 82.30% 190.30% 89.57% 84.83%
R&D to Revenue
29.52% 226.64% 184.06% 203.34% 213.21%
Operating Expenses to Revenue
40.85% 332.08% 374.36% 292.91% 298.04%
Earnings before Interest and Taxes (EBIT)
-145 -651 -524 -301 -134
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-114 -627 -504 -283 -118
Valuation Ratios
- - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
6.08 30.69 0.00 0.00 0.00
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
9.30 65.72 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
11.49 54.76 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - -
Debt to Equity
-2.86 -1.14 -2.09 -3.80 0.00
Long-Term Debt to Equity
-2.78 -1.10 -2.06 -3.78 0.00
Financial Leverage
-1.59 -1.37 -2.10 -3.19 0.00
Leverage Ratio
-1.61 -1.19 -2.04 -4.41 0.00
Compound Leverage Factor
-2.42 -1.19 -2.14 -2.19 0.00
Debt to Total Capital
153.75% 799.56% 191.66% 135.67% 0.00%
Short-Term Debt to Total Capital
4.26% 28.53% 3.23% 0.73% 0.00%
Long-Term Debt to Total Capital
149.49% 771.03% 188.43% 134.94% 0.00%
Preferred Equity to Total Capital
261.35% 922.51% 171.89% 263.09% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
-315.10% -1,622.07% -263.55% -298.76% 0.00%
Debt to EBITDA
-10.37 -1.70 -2.34 -1.82 0.00
Net Debt to EBITDA
-9.91 -1.61 -2.06 -1.53 0.00
Long-Term Debt to EBITDA
-10.08 -1.64 -2.30 -1.81 0.00
Debt to NOPAT
-11.62 -2.36 -3.23 -2.47 0.00
Net Debt to NOPAT
-11.11 -2.24 -2.85 -2.07 0.00
Long-Term Debt to NOPAT
-11.29 -2.28 -3.18 -2.45 0.00
Altman Z-Score
-1.16 -4.59 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio
-240.60% -152.86% -294.07% -737.48% 0.00%
Liquidity Ratios
- - - - -
Current Ratio
2.35 0.75 1.38 1.07 0.00
Quick Ratio
1.10 0.20 0.60 0.43 0.00
Cash Flow Metrics
- - - - -
Free Cash Flow to Firm (FCFF)
-741 -53 -544 -506 0.00
Operating Cash Flow to CapEx
-867.63% -673.68% -1,380.36% -561.54% -823.02%
Free Cash Flow to Firm to Interest Expense
-10.68 0.00 -19.90 0.00 0.00
Operating Cash Flow to Interest Expense
-6.71 0.00 -19.15 0.00 -0.38
Operating Cash Flow Less CapEx to Interest Expense
-7.48 0.00 -20.53 0.00 -0.42
Efficiency Ratios
- - - - -
Asset Turnover
0.53 0.10 0.14 0.16 0.00
Accounts Receivable Turnover
5.73 2.43 3.02 3.08 0.00
Inventory Turnover
4.83 5.87 4.57 3.00 0.00
Fixed Asset Turnover
2.23 0.41 0.66 1.20 0.00
Accounts Payable Turnover
6.61 6.54 6.35 4.02 0.00
Days Sales Outstanding (DSO)
63.69 150.49 120.93 118.54 0.00
Days Inventory Outstanding (DIO)
75.59 62.21 79.88 121.47 0.00
Days Payable Outstanding (DPO)
55.18 55.81 57.49 90.89 0.00
Cash Conversion Cycle (CCC)
84.11 156.90 143.33 149.12 0.00
Capital & Investment Metrics
- - - - -
Invested Capital
717 78 476 297 0.00
Invested Capital Turnover
1.46 0.34 0.25 0.63 0.00
Increase / (Decrease) in Invested Capital
639 -398 178 297 0.00
Enterprise Value (EV)
6,666 5,094 0.00 0.00 0.00
Market Capitalization
3,530 2,854 0.00 0.00 0.00
Book Value per Share
($9.07) ($8.70) ($6.53) $0.00 $0.00
Tangible Book Value per Share
($9.19) ($8.82) ($6.68) $0.00 $0.00
Total Capital
768 133 616 380 0.00
Total Debt
1,181 1,066 1,180 516 0.00
Total Long-Term Debt
1,148 1,028 1,160 513 0.00
Net Debt
1,129 1,010 1,040 433 0.00
Capital Expenditures (CapEx)
54 46 38 41 7.41
Debt-free, Cash-free Net Working Capital (DFCFNWC)
243 -65 -8.26 -17 0.00
Debt-free Net Working Capital (DFNWC)
294 -28 83 11 0.00
Net Working Capital (NWC)
262 -66 63 7.98 0.00
Net Nonoperating Expense (NNE)
130 101 148 -107 74
Net Nonoperating Obligations (NNO)
1,129 1,010 1,040 433 0.00
Total Depreciation and Amortization (D&A)
31 24 20 18 16
Debt-free, Cash-free Net Working Capital to Revenue
41.86% -70.28% -8.41% -17.98% 0.00%
Debt-free Net Working Capital to Revenue
50.72% -30.19% 84.94% 11.45% 0.00%
Net Working Capital to Revenue
45.09% -71.07% 64.65% 8.50% 0.00%
Earnings Adjustments
- - - - -
Adjusted Basic Earnings per Share
($0.87) ($2.43) ($2.60) $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding
301.81M 266.82M 248.65M 0.00 0.00
Adjusted Diluted Earnings per Share
($0.87) ($2.43) ($2.60) $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
301.81M 266.82M 248.65M 0.00 0.00
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
301.81M 266.82M 248.65M 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)
-102 -436 -365 -209 -96
Normalized NOPAT Margin
-17.52% -468.35% -372.17% -222.50% -138.63%
Pre Tax Income Margin
-37.49% -699.89% -562.15% -158.83% -420.12%
Debt Service Ratios
- - - - -
EBIT to Interest Expense
-2.09 0.00 -19.20 0.00 -0.83
NOPAT to Interest Expense
-1.47 0.00 -13.37 0.00 -0.60
EBIT Less CapEx to Interest Expense
-2.87 0.00 -20.59 0.00 -0.88
NOPAT Less CapEx to Interest Expense
-2.24 0.00 -14.76 0.00 -0.64
Payout Ratios
- - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% -0.75% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Alvotech

No quarterly metrics and ratios for Alvotech are available.


Frequently Asked Questions About Alvotech's Financials

When does Alvotech's fiscal year end?

According to the most recent income statement we have on file, Alvotech's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Alvotech's net income changed over the last 4 years?

Alvotech's net income appears to be on an upward trend, with a most recent value of -$231.86 million in 2024, rising from -$170.04 million in 2020. The previous period was -$551.73 million in 2023. View Alvotech's forecast to see where analysts expect Alvotech to go next.

What is Alvotech's operating income?
Alvotech's total operating income in 2024 was -$145.22 million, based on the following breakdown:
  • Total Gross Profit: $91.81 million
  • Total Operating Expenses: $237.03 million
How has Alvotech revenue changed over the last 4 years?

Over the last 4 years, Alvotech's total revenue changed from $69.45 million in 2020 to $580.28 million in 2024, a change of 735.6%.

How much debt does Alvotech have?

Alvotech's total liabilities were at $1.63 billion at the end of 2024, a 13.2% decrease from 2023, and a 122.8% increase since 2021.

How much cash does Alvotech have?

In the past 3 years, Alvotech's cash and equivalents has ranged from $11.16 million in 2023 to $66.43 million in 2022, and is currently $51.43 million as of their latest financial filing in 2024.

How has Alvotech's book value per share changed over the last 4 years?

Over the last 4 years, Alvotech's book value per share changed from 0.00 in 2020 to -9.07 in 2024, a change of -906.9%.



This page (NASDAQ:ALVO) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners